Exclusion Criteria:~* Any type of evident aphasia, which may interfere with patient's communication
difficulties caused by Alzheimer's disease~* History of severe drug allergy, or hypersensitivity, or patients
with known hypersensitivity to amantadine, lactose.~* Evidence (including CT/MRI results) of any clinically
significant central nervous system disease other than Alzheimer's disease.~* Modified Hachinski Ischemia score
greater than 4 at screening.~* Current evidence of clinically significant systemic disease~* Known or suspected
history of alcoholism or drug abuse within the past 10 years.~* Previous treatment with memantine or
participation in an investigational study with memantine.
